Talking O&G - a RANZCOG Podcast — Подкаст | Слушај онлајн на Radoxo

E26. Unpacking the Ethics of Novel Technology and Surgical Innovation (audio) 17.08.2026 30мин

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Naomi Holbeach about the ethics of use of novel technology and surgical innovation in obstetric and gynaecological practice. Dr Holbeach is an obstetrician and gynaecologist who holds a law degree and a PhD in bioethics. A/Prof Zeirideen Zaid and Dr Holbeach examine the legal, professional, and moral obligations held by medical practitioners, and how to align these with clinical decision making in the use of innovative technology, techniques, or devices. Dr Holbeach shares advice for clinicians wishing to engage in novel technology and surgical innovation to continue to improve care and provide more options for their patients. She highlights the importance of instilling informed consent and collaboration into all stages of the innovation process. 🔗 Resources mentioned in this episode: Good medical practice: a code of conduct for doctors in Australia Health Practitioner Regulation National Law Confidence-Based Surgical Innovation: A framework for responsible surgical innovation 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 This episode is eligible for CPD hours under the Educational Activities Domain as well as under the "Ethical practice" CAPE requirement. 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E26. Unpacking the Ethics of Novel Technology and Surgical Innovation (video) 17.08.2026 30мин

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Naomi Holbeach about the ethics of use of novel technology and surgical innovation in obstetric and gynaecological practice. Dr Holbeach is an obstetrician and gynaecologist who holds a law degree and a PhD in bioethics. A/Prof Zeirideen Zaid and Dr Holbeach examine the legal, professional, and moral obligations held by medical practitioners, and how to align these with clinical decision making in the use of innovative technology, techniques, or devices. Dr Holbeach shares advice for clinicians wishing to engage in novel technology and surgical innovation to continue to improve care and provide more options for their patients. She highlights the importance of instilling informed consent and collaboration into all stages of the innovation process. 🔗 Resources mentioned in this episode: Good medical practice: a code of conduct for doctors in Australia Health Practitioner Regulation National Law Confidence-Based Surgical Innovation: A framework for responsible surgical innovation 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 This episode is eligible for CPD hours under the Educational Activities Domain as well as under the "Ethical practice" CAPE requirement. 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E25. Preventable, Detectable, and Rising: Unpacking Endometrial Cancer Rates in Aotearoa New Zealand (audio) 03.08.2026 20мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Cecile Bergzoll speaks with Dr Silipa Naiqiso and Dr Sathana Ponnampalam about the rising rates of endometrial cancer in Aotearoa New Zealand. Cases of endometrial cancer are rising globally, and Aotearoa New Zealand has some of the fastest-rising rates in the world. However, there are significant barriers to care due to a lack of funding for areas such as diagnosis, molecular-directed care, and immunotherapy. Dr Naiqiso and Dr Ponnampalam examine these barriers, the strategies being developed to address the crisis, and advice for clinicians. They explore the changing demographic of women impacted by endometrial cancer and the equity gaps that exist for Māori and Pacific women. Dr Naiqiso and Dr Ponnampalam stress the need for a public awareness campaign in addition to advocating for funding to improve access to diagnosis and care in Aotearoa. 🔗 Resources mentioned in this episode: NZMJ: National and regional projections of gynaecological cancers in Aotearoa New Zealand: a projection model to 2045 highlighting an opportunity for collective action ANZJOG: Increasing incidence of endometrial cancer in Aotearoa New Zealand: Health professionals’ perspective ANZJOG: ‘It's not a solution to keep telling me to lose weight!’ Exploring endometrial cancer survivors’ experiences of nutrition and well-being advice: A qualitative study ANJZOG: Increasing incidence of endometrial carcinoma in a high-risk New Zealand community Assessment and Management of Abnormal Uterine Bleeding (AUB) in Non-Pregnant Women of Reproductive Age 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E25. Preventable, Detectable, and Rising: Unpacking Endometrial Cancer Rates in Aotearoa New Zealand (video) 03.08.2026 20мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Cecile Bergzoll speaks with Dr Silipa Naiqiso and Dr Sathana Ponnampalam about the rising rates of endometrial cancer in Aotearoa New Zealand. Cases of endometrial cancer are rising globally, and Aotearoa New Zealand has some of the fastest-rising rates in the world. However, there are significant barriers to care due to a lack of funding for areas such as diagnosis, molecular-directed care, and immunotherapy. Dr Naiqiso and Dr Ponnampalam examine these barriers, the strategies being developed to address the crisis, and advice for clinicians. They explore the changing demographic of women impacted by endometrial cancer and the equity gaps that exist for Māori and Pacific women. Dr Naiqiso and Dr Ponnampalam stress the need for a public awareness campaign in addition to advocating for funding to improve access to diagnosis and care in Aotearoa. 🔗 Resources mentioned in this episode: NZMJ: National and regional projections of gynaecological cancers in Aotearoa New Zealand: a projection model to 2045 highlighting an opportunity for collective action ANZJOG: Increasing incidence of endometrial cancer in Aotearoa New Zealand: Health professionals’ perspective ANZJOG: ‘It's not a solution to keep telling me to lose weight!’ Exploring endometrial cancer survivors’ experiences of nutrition and well-being advice: A qualitative study ANJZOG: Increasing incidence of endometrial carcinoma in a high-risk New Zealand community Assessment and Management of Abnormal Uterine Bleeding (AUB) in Non-Pregnant Women of Reproductive Age 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E24. Recommendations for Embedding Informed Consent in Clinical Practice (video) 20.07.2026 1ч 2мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Vijaya Karanam speaks to obstetrician Dr Penny Sheehan, consumer Yvonne Maringa, and midwife Deborah Pidd about the vital role informed consent plays in everyday clinical practice. They outline the fundamentals of the recently released signposting guideline Consent and provision of information to patients regarding proposed treatments (C-Gen 2). Dr Sheehan and Ms Pidd discuss the responsibilities of clinicians to ensure patients are informed, respected, and feel empowered to ask questions and engage in shared decision-making. They emphasise that consent is relational, not transactional, and establishing a relationship of trust is essential. Ms Maringa shares what good informed consent looks like and means to the patient, and how clinicians can help them to feel informed and safe even in high-pressure, time-sensitive situations. They all highlight the importance of patient-centred, culturally responsive, and individualised care as core aspects of embedding informed consent into practice. 🔗 Resources mentioned in this episode: Consent and provision of information to patients regarding proposed treatment (C-Gen 2) Signposting Statement to National Guidance Safer Care Victoria: Respectful Maternity and Newborn Care Framework The Mothers on Respect (MOR) index: measuring quality, safety, and human rights in childbirth The Mother’s Autonomy in Decision Making (MADM) scale: Patient-led development and psychometric testing of a new instrument to evaluate experience of maternity care 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E24. Recommendations for Embedding Informed Consent in Clinical Practice (audio) 20.07.2026 1ч 2мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Vijaya Karanam speaks to obstetrician Dr Penny Sheehan, consumer Yvonne Maringa, and midwife Deborah Pidd about the vital role informed consent plays in everyday clinical practice. They outline the fundamentals of the recently released signposting guideline Consent and provision of information to patients regarding proposed treatments (C-Gen 2). Dr Sheehan and Ms Pidd discuss the responsibilities of clinicians to ensure patients are informed, respected, and feel empowered to ask questions and engage in shared decision-making. They emphasise that consent is relational, not transactional, and establishing a relationship of trust is essential. Ms Maringa shares what good informed consent looks like and means to the patient, and how clinicians can help them to feel informed and safe even in high-pressure, time-sensitive situations. They all highlight the importance of patient-centred, culturally responsive, and individualised care as core aspects of embedding informed consent into practice. 🔗 Resources mentioned in this episode: Consent and provision of information to patients regarding proposed treatment (C-Gen 2) Signposting Statement to National Guidance Safer Care Victoria: Respectful Maternity and Newborn Care Framework The Mothers on Respect (MOR) index: measuring quality, safety, and human rights in childbirth The Mother’s Autonomy in Decision Making (MADM) scale: Patient-led development and psychometric testing of a new instrument to evaluate experience of maternity care 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E23. Unpacking the Impact of the Safer Baby Bundle and Recommendations for Implementation (audio) 06.07.2026 37мин

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Keeth Mayakaduwage and Dr Penny Sheehan about the impacts and implementation of the Safer Baby Bundle, Australia’s national initiative to reduce the number of stillborn babies by 20%. Dr Mayakaduwage and Dr Sheehan outline the context of stillbirth in Australia and the targets of the Safer Baby Bundle. They examine the key components of the bundle, including its cultural adaptations for First Nations and migrant and refugee communities. Dr Mayakaduwage presents the central findings of an ANZJOG research series which examined the early impacts of the bundle in Victoria, on which he was lead author. Dr Sheehan shares her experience implementing the bundle in clinical practice and provides recommendations for clinicians wishing to strengthen its impact in their own jurisdictions. 🔗 Resources mentioned in this episode: The Safer Baby Bundle Stronger Bubba Born Growing a Healthy Baby Stillbirth Centre of Research Excellence eLearning Resources ANZJOG: Reducing Perinatal Mortality in Victoria, Australia: Early Insights from the Safer Baby Bundle Implementation ANZJOG: Impacts on Causes of Perinatal Death After Safer Baby Bundle Implementation in Victoria, Australia ANZJOG: Reach and Impact of the Safer Baby Bundle Among Groups Disproportionately Affected by Stillbirth in Victoria, Australia 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E23. Unpacking the Impact of the Safer Baby Bundle and Recommendations for Implementation (video) 06.07.2026 37мин

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Roshan Zeirideen Zaid speaks to Dr Keeth Mayakaduwage and Dr Penny Sheehan about the impacts and implementation of the Safer Baby Bundle, Australia’s national initiative to reduce the number of stillborn babies by 20%. Dr Mayakaduwage and Dr Sheehan outline the context of stillbirth in Australia and the targets of the Safer Baby Bundle. They examine the key components of the bundle, including its cultural adaptations for First Nations and migrant and refugee communities. Dr Mayakaduwage presents the central findings of an ANZJOG research series which examined the early impacts of the bundle in Victoria, on which he was lead author. Dr Sheehan shares her experience implementing the bundle in clinical practice and provides recommendations for clinicians wishing to strengthen its impact in their own jurisdictions. 🔗 Resources mentioned in this episode: The Safer Baby Bundle Stronger Bubba Born Growing a Healthy Baby Stillbirth Centre of Research Excellence eLearning Resources ANZJOG: Reducing Perinatal Mortality in Victoria, Australia: Early Insights from the Safer Baby Bundle Implementation ANZJOG: Impacts on Causes of Perinatal Death After Safer Baby Bundle Implementation in Victoria, Australia ANZJOG: Reach and Impact of the Safer Baby Bundle Among Groups Disproportionately Affected by Stillbirth in Victoria, Australia 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E22. ISSVD Terminology for Vulvar Intraepithelial Neoplasia (VIN) and Squamos Intraepithelial Lesions (SIL) (audio) 22.06.2026 20мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare speaks with Conj A/Prof Tania Day about gynaecologists' role in prevention of vulvar squamous cell carcinoma by identifying and treating vulvar intraepithelial neoplasia (VIN) and distinguishing these from benign squamous intraepithelial lesions (SIL). They unpack the recently published 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology guide, on which Conj A/Prof Day was lead author. The ISSVD terminology was last updated in 2015, and there have since been major advancements in the clinical understanding of VIN histopathology and immunohistochemistry. Dr Clare and Conj A/Prof Day examine these developments, outlining the new preferred terminology, as well as diagnosis, treatment, and follow up. They highlight the importance of consistent language to aid collective efforts in vulval cancer elimination. 🔗 Resources mentioned in this episode: 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology for vulvar intraepithelial neoplasia and squamous intraepithelial lesions 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E22. ISSVD Terminology for Vulvar Intraepithelial Neoplasia (VIN) and Squamos Intraepithelial Lesions (SIL) (video) 22.06.2026 20мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare speaks with Conj A/Prof Tania Day about gynaecologists' role in prevention of vulvar squamous cell carcinoma by identifying and treating vulvar intraepithelial neoplasia (VIN) and distinguishing these from benign squamous intraepithelial lesions (SIL). They unpack the recently published 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology guide, on which Conj A/Prof Day was lead author. The ISSVD terminology was last updated in 2015, and there have since been major advancements in the clinical understanding of VIN histopathology and immunohistochemistry. Dr Clare and Conj A/Prof Day examine these developments, outlining the new preferred terminology, as well as diagnosis, treatment, and follow up. They highlight the importance of consistent language to aid collective efforts in vulval cancer elimination. 🔗 Resources mentioned in this episode: 2026 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology for vulvar intraepithelial neoplasia and squamous intraepithelial lesions 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E21. Unpacking RANZCOG’s Intrapartum Fetal Surveillance Clinical Guideline (audio) 05.06.2026 19мин

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Penny Sheehan about RANZCOG’s updated binational clinical guideline for Intrapartum Fetal Surveillance (C-Obs 1). They discuss recommendations for antenatal and intrapartum risk factors and models of care, cases involving fetal sepsis, the use of tocolysis in cases of prolonged deceleration, and more. They look at the evidence around alternative methods for fetal assessment, such as fetal scalp stimulation and fetal blood sampling, and new and emerging technologies. The broader process of the guideline development is also explored, including the implementation of the GRADE system to assess evidence, and the guiding principles of care addressed in the guideline. 🔗 Resources mentioned in this episode: Intrapartum Fetal Surveillance (C-Obs 1) Clinical Guideline Respectful Maternity and Newborn Care Framework Fetal Surveillance Education Program (FSEP) 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E21. Unpacking RANZCOG’s Intrapartum Fetal Surveillance Clinical Guideline (video) 05.06.2026 19мин

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Penny Sheehan about RANZCOG’s updated binational clinical guideline for Intrapartum Fetal Surveillance (C-Obs 1). They discuss recommendations for antenatal and intrapartum risk factors and models of care, cases involving fetal sepsis, the use of tocolysis in cases of prolonged deceleration, and more. They look at the evidence around alternative methods for fetal assessment, such as fetal scalp stimulation and fetal blood sampling, and new and emerging technologies. The broader process of the guideline development is also explored, including the implementation of the GRADE system to assess evidence, and the guiding principles of care addressed in the guideline. 🔗 Resources mentioned in this episode: Intrapartum Fetal Surveillance (C-Obs 1) Clinical Guideline Respectful Maternity and Newborn Care Framework Fetal Surveillance Education Program (FSEP) 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E20. Recommendations for Multidisciplinary Treatment of Persistent Pelvic Pain (audio) 25.05.2026 39мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks with Dr Marilla Druitt about multidisciplinary management and treatment options for persistent pelvic pain. Pelvic pain affects one in five women in Australia and up to one in four women in Aotearoa New Zealand at some point in their life. Contributors are broad, and may include conditions such endometriosis or adenomyosis, antenatal or postpartum pain, or irritable bowel syndrome. Dr Waterfall and Dr Druitt address a range of treatment and prevention approaches, including hormonal treatment, physiotherapy, pain psychology, nutrition, and more. They highlight the biopsychosocial components of pelvic pain and its comorbidities and recommend a holistic approach to care. They also emphasise the importance of focusing on prevention, to reduce the potential development of severe pain. This episode was recorded in February 2026. Please refer to the PBS website for up-to-date information on medication availability and subsidies. 🔗 Resources mentioned in this episode: Australian Living Evidence Guideline: Endometriosis Pelvic Pain Foundation of Australia: Stretches, Strategies and Acupressure Guides Queensland Government Flowchart: Acute presentation of persistent pelvic pain Greene Climacteric Scale 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E20. Recommendations for Multidisciplinary Treatment of Persistent Pelvic Pain (video) 25.05.2026 39мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Heather Waterfall speaks with Dr Marilla Druitt about multidisciplinary management and treatment options for persistent pelvic pain. Pelvic pain affects one in five women in Australia and up to one in four women in Aotearoa New Zealand at some point in their life. Contributors are broad, and may include conditions such endometriosis or adenomyosis, antenatal or postpartum pain, or irritable bowel syndrome. Dr Waterfall and Dr Druitt address a range of treatment and prevention approaches, including hormonal treatment, physiotherapy, pain psychology, nutrition, and more. They highlight the biopsychosocial components of pelvic pain and its comorbidities and recommend a holistic approach to care. They also emphasise the importance of focusing on prevention, to reduce the potential development of severe pain. This episode was recorded in February 2026. Please refer to the PBS website for up-to-date information on medication availability and subsidies. 🔗 Resources mentioned in this episode: Australian Living Evidence Guideline: Endometriosis Pelvic Pain Foundation of Australia: Stretches, Strategies and Acupressure Guides Queensland Government Flowchart: Acute presentation of persistent pelvic pain Greene Climacteric Scale 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E19. Unpacking the Clinical Utility of Maternal TORCH Screening in Fetal Growth Restriction (audio) 11.05.2026 14мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Nisha Khot speaks with Professor Lisa Hui and Associate Professor Natasha Holmes about the clinical utility of TORCH – Toxoplasma gondii, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) – serology in isolated fetal growth restriction (FGR). Professor Hui and A/Prof Holmes co-authored a study on this topic, considering whether TORCH serology should continue to be ordered for isolated FGR. They examine the importance of differentiating early- and late-onset FGR, how their findings reflect international screening recommendations, and whether TORCH screening can be a reassuring measure for patients. They highlight the waste of resources and potential increase of maternal anxiety associated with ordering TORCH serology in situations where it is clinically unnecessary. 🔗 Resources mentioned in this episode: Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E19. Unpacking the Clinical Utility of Maternal TORCH Screening in Fetal Growth Restriction (video) 11.05.2026 14мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Nisha Khot speaks with Professor Lisa Hui and Associate Professor Natasha Holmes about the clinical utility of TORCH – Toxoplasma gondii, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV) – serology in isolated fetal growth restriction (FGR). Professor Hui and A/Prof Holmes co-authored a study on this topic, considering whether TORCH serology should continue to be ordered for isolated FGR. They examine the importance of differentiating early- and late-onset FGR, how their findings reflect international screening recommendations, and whether TORCH screening can be a reassuring measure for patients. They highlight the waste of resources and potential increase of maternal anxiety associated with ordering TORCH serology in situations where it is clinically unnecessary. 🔗 Resources mentioned in this episode: Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E18. Recommendations for the Diagnosis and Treatment of Vulvovaginal Candidiasis (VVC) and Bacterial Vaginosis (BV) (audio) 27.04.2026 22мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare and Conjoint Associate Professor Tania Day discuss diagnosis and treatment recommendations for vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) – two common and impactful conditions with high recurrence rates. Dr Clare and Conj A/Prof Day examine recent and emerging research on these conditions, unpack common myths and misconceptions, and discuss their experiences diagnosing and treating them in their clinical practice. They touch on a range of long-term management strategies including male partner treatment of BV and the role of the microbiome in both conditions. 🔗 Resources mentioned in this episode: Recommendations for the Diagnosis and Treatment of Vaginitis Clinician instructions for BV partner treatment Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations Nature Reviews Disease Primer: Bacterial vaginosis 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E18. Recommendations for the Diagnosis and Treatment of Vulvovaginal Candidiasis (VVC) and Bacterial Vaginosis (BV) (video) 27.04.2026 22мин

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Anna Clare and Conjoint Associate Professor Tania Day discuss diagnosis and treatment recommendations for vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) – two common and impactful conditions with high recurrence rates. Dr Clare and Conj A/Prof Day examine recent and emerging research on these conditions, unpack common myths and misconceptions, and discuss their experiences diagnosing and treating them in their clinical practice. They touch on a range of long-term management strategies including male partner treatment of BV and the role of the microbiome in both conditions. 🔗 Resources mentioned in this episode: Recommendations for the Diagnosis and Treatment of Vaginitis Clinician instructions for BV partner treatment Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations Nature Reviews Disease Primer: Bacterial vaginosis 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

E17. Unpacking RANZCOG’s Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology Clinical Guideline (audio) 13.04.2026 25мин

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Natasha Frawley and Dr Magdalena Halt about RANCOG’s new clinical guideline for Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29). This guideline builds on and broadens the scope of the College’s 2009 Position Statement on Robotic Assisted Laparoscopy. Robotic assisted surgery is growing rapidly – as of May 2023, there were 162 robotic surgical platforms in Australia and Aotearoa New Zealand, and this number continues to rise. Dr Frawley and Dr Halt explore the current evidence surrounding robotic assisted gynaecological surgery compared to open or laparoscopic procedures, areas that require further research, and the environmental implications of this approach. They discuss their own clinical experiences with robotic platforms and highlight some of the access issues currently associated with robotic assisted surgery. 🔗 Resources mentioned in this episode: Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29) Clinical Guideline 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). This podcast is not sponsored by any technology companies. Our aim is to deliver balanced, evidence-based discussion. Any views expressed are those of the speaker and do not reflect brand endorsement by RANZCOG.

E17. Unpacking RANZCOG’s Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology Clinical Guideline (video) 13.04.2026 25мин

In this episode of Talking O&G: a RANZCOG Podcast, host A/Prof Scott White speaks to Dr Natasha Frawley and Dr Magdalena Halt about RANCOG’s new clinical guideline for Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29). This guideline builds on and broadens the scope of the College’s 2009 Position Statement on Robotic Assisted Laparoscopy. Robotic assisted surgery is growing rapidly – as of May 2023, there were 162 robotic surgical platforms in Australia and Aotearoa New Zealand, and this number continues to rise. Dr Frawley and Dr Halt explore the current evidence surrounding robotic assisted gynaecological surgery compared to open or laparoscopic procedures, areas that require further research, and the environmental implications of this approach. They discuss their own clinical experiences with robotic platforms and highlight some of the access issues currently associated with robotic assisted surgery. 🔗 Resources mentioned in this episode: Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29) Clinical Guideline 📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733 💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care. The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). This podcast is not sponsored by any technology companies. Our aim is to deliver balanced, evidence-based discussion. Any views expressed are those of the speaker and do not reflect brand endorsement by RANZCOG.

Talking O&G - a RANZCOG Podcast

Епизоди

Популарен во

Talking O&G - a RANZCOG Podcast

Епизоди

Слични подкасти

Популарен во